OP7H:PA:PA-Ossiam Bloomberg USA PAB UCITS ETF - 1A EUR Hedged Acc (EUR)

ETF | Others |

Last Closing

USD 116.1824

Change

0.00 (0.00)%

Market Cap

N/A

Volume

233.00
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-04-10 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
JPX4:PA Amundi Index Solutions - Amund..

+0.40 (+0.93%)

USD 55.57B
SPY5:PA SPDR® S&P 500 UCITS ETF EUR

-7.15 (-1.51%)

USD 13.81B
SP5C:PA Lyxor S&P 500 UCITS ETF - C-EU..

-4.66 (-1.38%)

USD 12.91B
WRD:PA HSBC MSCI World UCITS ETF

-0.33 (-1.06%)

USD 11.43B
MEUD:PA Amundi Stoxx Europe 600 UCITS ..

-0.56 (-0.23%)

USD 9.42B
EQQQ:PA Invesco EQQQ NASDAQ-100 UCITS ..

-8.45 (-2.11%)

USD 8.68B
WLD:PA Lyxor UCITS MSCI World D-EUR

-2.86 (-0.93%)

USD 7.98B
HHH:PA HSBC S&P 500 UCITS ETF

-0.79 (-1.65%)

USD 7.67B
HSTE:PA HSBC ETFS PLC - HSBC Hang Seng..

-0.03 (-0.57%)

USD 6.16B
SPY4:PA SSgA SPDR S&P 400 US Mid Cap

-0.60 (-0.80%)

USD 5.54B

ETFs Containing OP7H:PA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -15.59% 19% F 23% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -15.59% 18% F 23% F
Trailing 12 Months  
Capital Gain -3.24% 38% F 53% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -3.24% 35% F 50% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 9.16% 55% F 63% D
Dividend Return 9.16% 54% F 79% B-
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 11.80% 54% F 86% B+
Risk Adjusted Return 77.61% 55% F 85% B
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike